12:00 AM
 | 
Feb 18, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

FluGen preclinical data

In mice, a single dose of intranasal M2SR provided broad-spectrum, long-lasting cross-protective immunity against multiple subtypes...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >